The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Open accessAbstract
OBJECTIVE: Assess Aβ deposition longitudinally and explore its relationship with cognition and disease progression. METHODS: Clinical follow-up was obtained 20 ± 3 months after [¹¹C]Pittsburgh compound B (PiB)-positron emission tomography in 206 subjects: 35 with dementia of the Alzheimer type (DAT), 65 with mild cognitive impairment (MCI), and 106 age-matched healthy controls (HCs). A second PiB scan was obtained at follow-up in 185 subjects and a third scan after 3 years in 57. RESULTS: At baseline, 97% of DAT, 69% of MCI, and 31% of HC subjects showed high PiB retention. At 20-month follow-up, small but significant increases in PiB standardized uptake value ratios were observed in the DAT and MCI groups, and in HCs with high PiB retention at baseline (5.7%, 2.1%, and 1.5%, respectively). Increases were associated with the number of apolipoprotein E ε4 alleles. There was a weak correlation between PiB increases and decline in cognition when all groups were combined. Progression to DAT occurred in 67% of MCI with high PiB versus 5% of those with low PiB, but 20% of the low PiB MCI subjects progressed to other dementias. Of the high PiB HCs, 16% developed MCI or DAT by 20 months and 25% by 3 years. One low PiB HC developed MCI. INTERPRETATION: Aβ deposition increases slowly from cognitive normality to moderate severity DAT. Extensive Aβ deposition precedes cognitive impairment, and is associated with ApoE genotype and a higher risk of cognitive decline in HCs and progression from MCI to DAT over 1 to 2 years. However, cognitive decline is only weakly related to change in Aβ burden, suggesting that downstream factors have a more direct effect on symptom progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and that progression of biomarker measures is also a continuous process that begins before symptoms [9–14]”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous studies have shown that CU individuals with abnormal amyloid biomarkers have more rapid progression of atrophy, hypometabolism, and clinical/cognitive decline than individuals without biomarker evidence of Aβ deposition [13,33,80,93–99]”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ε4 allele increased brain amyloid burden in a dose-dependent manner in normal elderly individuals and in mild cognitive impairment patients [93,94].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [94]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a study characterizing sporadic AD, for instance, Villemagne et al. used Pittsburgh compound B (PiB) positron emission tomography (PET) to show that 31% of healthy control subjects had high PiB retention indicating Aß deposition and of these, 25% developed mild cognitive impairment or AD by 3 years (Villemagne et al., 2011).”
From Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model (2022) · cites this paper as Villemagne et al., 2011
In the citing paper
“Previous longitudinal studies have either failed to detect an early increase in regional Aβ deposition16 or identified a rather large early stage Aβ region including the posterior temporal, inferior parietal, posterior cingulate, precuneus, and occipital areas4.”
From Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity (2017) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Self-citationVitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Design and construction of a realistic digital brain phantom
Collins, D. L., Zijdenbos, A. P., Kollokian, V., Sled, J. G., Kabani, N. J., Holmes, C. J., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.712135 · Cited by 1,825
Mitchell, A. J., & Shiri‐Feshki, M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01326.x · Cited by 1,659
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Imaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104
Self-citationJack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 836
Amyloid imaging for Alzheimer's disease
Kerchner, G. A. (2011) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.617365 · Cited by 2
Standardization of MRI and Amyloid Imaging
Grothe, M. J., Kurth, J., Hampel, H. J., Krause, B. J., & Teipel, S. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-411464-7.00009-2 · Cited by 2
Nair, A. K., Ramaswamy, S., Kan, K., & Nair, S. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000330 · Cited by 2
Kimura, Y., Kato, T., Ito, K., & Ichise, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-39457-8_4 · Cited by 2
Pardo, F. J. P., Vicente, A. M. G., Amo‐Salas, M., Marín, B. M., Muñoz, S. N., Hortelano, P. G., Medina, I. R., Pérez, E. G., Bermejo, A. P., García, V. M. P., et al. (2022) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004370 · Cited by 2
Hatashita, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00019-7 · Cited by 2
Neuroinflammation in depression
Dobos, N. (2014) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
3D Mapping Reveals Network-specific Amyloid Progression and Subcortical SusceptibilityPreprint
Canter, R. G., Choi, H., Wang, J., Watson, L. A., Yao, C., Abdurrob, F., Bousleiman, S. M., Delalle, I., Chung, K., & Tsai, L.-H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/116244 · Cited by 2
Borelli, W. V., Leal‐Conceição, E., Andrade, M. A., Esper, N. B., Feltes, P. K., Soder, R. B., Matushita, C. S., Hartmann, L. M., Radaelli, G., Schilling, L. P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/666438 · Cited by 2
Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions
Villemagne, V. L., Doré, V., Burnham, S. C., & Rowe, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_10 · Cited by 2
Self-citationUpdate Amyloid-Bildgebung in der Diagnostik der Neurodegeneration
Drzezga, A. E., & Giehl, K. (2022) · Angewandte Nuklearmedizin · doi:10.1055/a-1712-6110 · Cited by 1
Can Structural MRIs be used to Detect Amyloid Positivity using Deep Learning?
Chattopadhyay, T., Komandur, D., Naik, J., Buwa, K., Ozarkar, S. S., Thomopoulos, S. I., & Thompson, P. M. (2023) · International Symposium on Medical Information Processing and Analysis (SIPAIM) · doi:10.1109/sipaim56729.2023.10373510 · Cited by 1
Xie, Y., Meng, X. W., Li, T., Zhang, H., Zheng, Y., Kim, S.-Y., Zhang, C., Yu, X., & Wang, H. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70064 · Cited by 1
Volloch, V., & Rits‐Volloch, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094252 · Cited by 3
Bayır, G., Dal, D. Y., Harı, E., Ay, U., Gurvit, H. I., Kabakçıoğlu, A., & Acar, B. (2025) · Bioengineering · doi:10.3390/bioengineering12080819 · Cited by 1
Jung, D. H., Son, G., Wang, S. M., Yoo, S., Jahanshahi, A., Lim, H. K., & Moon, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-15230-2 · Cited by 1
LNODE: Uncovering the Latent Dynamics of $$\text {A}\beta $$ in Alzheimer’s Disease
Wen, Z., & Biros, G. (2025) · Lecture notes in computer science · doi:10.1007/978-3-032-05182-0_31 · Cited by 1
Bednorz, A., & Religa, D. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1779076 · Cited by 1
Chien, S.-C., Chang, I.-Y., Chen, Y., Lai, Y.-Z., Chen, Y., Sun, P., Li, B., Wang, Y., & Chen, J.-C. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345949 · Cited by 1
Dementia Due to Neurodegenerative Disease: Molecular Imaging Findings
Ossenkoppele, R., Booij, J., Scheltens, P., & van Berckel, B. N. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_9 · Cited by 1
Diagnostic précoce de la maladie d’Alzheimer
Saint‐Aubert, L., Puel, M., Chollet, F., & Pariente, J. (2012) · Revue Neurologique · doi:10.1016/j.neurol.2012.07.006 · Cited by 4
Ashraf, A., Mehta, P. D., & Edison, P. (2012) · Reviews in Clinical Gerontology · doi:10.1017/s0959259812000160 · Cited by 1
PET in Neurological and Psychiatric Disorders: Technologic Advances and Clinical Applications
Matusch, A., & Kroll, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-40070-9_20 · Cited by 1
Subclinical memory impairment in unaffected siblings of patients with dementia
Hewawasam, C., Wickramasinghe, A., Caldera, M. C., & Dassanayake, T. L. (2023) · The Clinical Neuropsychologist · doi:10.1080/13854046.2023.2182832 · Cited by 1
Neuroimaging Biomarkers in Alzheimer’s Disease and Related Disorders
Masdeu, J. C., & Pascual, B. (2023) · Springer eBooks · doi:10.1007/978-3-031-43356-6_11 · Cited by 1
Movement Disorders in Alzheimer’s Disease
STARKSTEIN, S. E., & Merello, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6365-7_8 · Cited by 1
Pre-clinical Diagnosis of Neurodegenerative Diseases
Oizumi, H., & Takeda, A. (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.323 · Cited by 1
Focal Ab-amyloid deposition precedes cerebral microbleeds and Superficial siderosis: a case report
Raniga, P., Desmond, P., Yates, P., Salvado, O., Bourgeat, P., Fripp, J., Pejoska, S., Woodward, M., Rowe, C. C., & Villemagne, V. L. (2017) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001007 · Cited by 1
Self-citationTau Imaging in Preclinical Alzheimer’s Disease
Edison, P. (2018) · Neuromethods · doi:10.1007/978-1-4939-7674-4_13 · Cited by 1
Negative 11C-PIB PET Predicts Lack of Alzheimer’s Disease Pathology in Postmortem Examination
Scheinin, N. M., Gardberg, M., Röyttä, M., & Rinne, J. O. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170569 · Cited by 1
Sex and the Aging Immune System
Gibson, D. C., & Bupp, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00059-2 · Cited by 1
Masters, C. L., Gu, B. J., Laws, S. M., Lim, Y. Y., Roberts, B. R., Villemagne, V. L., & Beyreuther, K. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00003-1 · Cited by 1
Self-citationNouvelles techniques d’imagerie cérébrale, potentiel pour la maladie d’Alzheimer
Bihan, D. L. (2020) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2020.01.003 · Cited by 4
Does genetic risk help to predict amyloid burden in a non-demented population? A Bayesian approachPreprint
Voyle, N., Jansen, W. J., Keohane, A., Patel, H., Folarin, A., Newhouse, S., Johnston, C., Lin, K., Visser, P. J., Hodges, A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/174995 · Cited by 1
Evaluation of a cognitive and a morphometric marker for the early detection of Alzheimer's disease
Kälin, A. M. (2015) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-117647 · Cited by 1
Cummins, T. L. (2018) · Minerva Access (University of Melbourne) · Cited by 1
Moallemian, S., Salmon, É., Bahri, M. A., Beliy, N., Delhaye, E., Balteau, E., Phillips, C. L. M., & Bastin, C. (2023) · medRxiv · doi:10.1101/2023.04.14.23288516 · Cited by 1
Lecy, E. E., Min, H.-K. P., Apgar, C. J., Maltais, D. D., Lundt, E. S., Albertson, S. M., Senjem, M. L., Schwarz, C. G., Botha, H., Graff‐Radford, J., et al. (2023) · medRxiv · doi:10.1101/2023.05.14.23289948 · Cited by 1
Genome-wide meta-analysis of CSF biomarkers in Alzheimer’s disease and Parkinson’s disease cohortsPreprint
Ta, M., Blauwendraat, C., Antar, T., Leonard, H. L., Singleton, A., Nalls, M. A., Iwaki, H., Initiative, A. D. N., & Biomarkers, T. F. I. F. N. D. O. (2023) · medRxiv · doi:10.1101/2023.06.13.23291354 · Cited by 1
Bevan, R. J., Maguire, E., Phillips, T. J., Simonazzi, E., Vassileva, M., Williams, J. H., & Taylor, P. R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.22.558987 · Cited by 1
Brown, C., Cousins, K. A. Q., Korecka, M., McGrew, E., Chen‐Plotkin, A. S., Detre, J. A., McMillan, C. T., Lee, E. B., Das, S. R., Mechanic-Hamilton, D. J., et al. (2025) · medRxiv · doi:10.1101/2025.09.04.25334935 · Cited by 1
Bhargava, V., Wang, M. S., Chen, Y., Luo, J., Weiner, M. W., Landau, S. M., Jagust, W., Sabbagh, M. N., Su, Y., Reiman, E. M., et al. (2025) · medRxiv · doi:10.1101/2025.09.19.25336123 · Cited by 1
Koole, M. J. B., Vunckx, K., Verhaeghe, J. A. J., Laere, K. V., & van Laar, P. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_5
Woodruff‐Pak, D. S., & Raber, J. (2012) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-011-0001-2
CSF biomarking for diagnosis and treatment assessment in neurodegeneration
Hardy, J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07928.x
SPECIFIC AMYLOID-BETA OLIGOMERS IN HUMAN CEREBROSPINAL FLUID
Handoko, M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Lack of Association of Apolipoprotein E ɛ4 Genotype with Cognitive Dysfunction in Essential Tremor
Oh, Y., Kim, J., Kim, Y.-I., Yang, D., & Lee, K.-S. (2012) · International journal of gerontology · doi:10.1016/j.ijge.2012.11.001
Impact of the IWG/Dubois Criteria for Alzheimer’s Disease in Imaging Studies
Dubois, B., & Uspenskaya, O. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_13
Evaluation of cognitive performance within the disease course of Alzheimers
Neuropsychology, M. T. (2013)
Modulation of Alzheimer's Disease Pathology and Neuroplasticity by Environmental Factors
Hu, Y. (2012) · Figshare
Ocular biomarkers for early detection and monitoring of Alzheimer's disease
Frost, S. M. (2013) · UWA Profiles and Research Repository (UWA)
Wang, X. R. (2015) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27084
Price, J. C., Lopresti, B. J., & Villemagne, V. L. (2012) · Neuromethods · doi:10.1007/7657_2012_47
Self-citationWelche Rolle spielt das Amyloid-PET für die Diagnose?
Teipel, S. J. (2015) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-015-1450-5
Zerebrale Bildgebung bei Demenzen: State-of-the-Art Brain Imaging in Dementia: State-of-the-Art
Boelmans, K., & Buchert, R. (2013)
PET Imaging as a Diagnostic Tool in Alzheimer’s Disease
Rinne, J. O. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_13
Drzezga, A. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-30081-8_26
Frontiers in Clinical Drug Research - Alzheimer Disorders
Marei, H. E., Althani, A., Suhonen, J., El Zowalaty, M. E., Albanna, M. A., Cenciarelli, C., Wang, T., & Caceci, T. (2016) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97816810823181160501
Advances in Neuroimaging Techniques with PET
Shimosegawa, E. (2016) · Springer eBooks · doi:10.1007/978-4-431-54598-9_8
Imaging Approaches to Cerebral Cortex Pathology
Bartha, R., & Lee, T.-Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00003-3
Croft, C. L. (2016) · Research Portal (King's College London)
Imaging Amnestic Mild Cognitive Impairment: Neuroinflammation, Beta-amyloid and Glutathione
Knezevic, D. (2016) · TSpace (University of Toronto)
Memory decline and Aβ amyloid as markers of neurodegeneration in preclinical Alzheimer's disease
Lim, Y. Y. (2013) · Minerva Access (University of Melbourne)
Microglia phenotypes in aging-associated diseases
Yin, Z. (2017) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Can Exposure to Volatile Anesthetics Be a Tipping Point for AD Susceptible Populations?
Niesman, I. (2017) · Annals of Alzheimer s and Dementia Care · doi:10.17352/aadc.000002
Estrogen Receptor β Regulates Brain Signaling Involved in Depression
Chhibber, A. (2016) · KU ScholarWorks (The University of Kansas)
Synthesis and characterization of fluorescent stilbene-based probes targeting amyloid fibrils
Zhang, J. (2018) · Linköping studies in science and technology. Dissertations · doi:10.3384/diss.diva-152345
Amyloid-β PET Imaging in Aging and Dementia
Tolboom, N., Ossenkoppele, R., & van Berckel, B. N. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-01523-7_11
Exploring the Role of Somatostatin in the Pathogenesis of Alzheimer’s disease
Solarski, M. (2018) · TSpace (University of Toronto)
Patel, S. (2019) · TSpace (University of Toronto)
Limitations of amyloid imaging in Alzheimer's disease
Weidman, D. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00031-1
APOE as a Risk Factor for Age‐Related Cognitive Impairment
Korthauer, L. E., & Driscoll, I. F. (2020) · The Wiley Encyclopedia of Health Psychology · doi:10.1002/9781119057840.ch35
Huang, Y. H., Jia, H., & Bao, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00013-6
Tau Imaging in Neurodegenerative Dementia
Ponisio, M. R., Iranpour, P., & Benzinger, T. L. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_12
Amyloid imaging in alzheimer’s disease: A literature review
Saidlitz, P., Voisin, T., Vellas, B. J., Payoux, P., Gabelle, A., Formaglio, M., & Delrieu, J. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0485-5
Schramm, G., Laere, K. V., van Laar, P. J., & Koole, M. J. B. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_6
Saint‐Aubert, L. (2012) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)
Von symptombasierter Diagnostik hin zu einem biologischen Konzept
Bungenberg, J., Costa, A. S., & Reetz, K. (2022) · NeuroTransmitter · doi:10.1007/s15016-022-9371-2
Kilimann, I., & Teipel, S. J. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-21882-8.00014-1
Misquitta, K., Rosen, H. J., & Tartaglia, M. C. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.004
Tuzzi, E., Loktyushin, A., Zeller, A., Pohmann, R., Laske, C., Scheffler, K., & Hagberg, G. E. (2022) · medRxiv · doi:10.1101/2022.09.23.22280290
The potential of extracellular vesicle lipid profiling in Alzheimer's disease.Preprint
Su, H., Masters, C. L., Bush, A. I., Barnham, K. J., Reid, G. E., & Vella, L. J. (2023) · doi:10.22541/au.168388562.25020996/v1
Self-citationShin, M.-G., Lee, Y. M., Kim, Y. J., Lee, H., Pak, K., & Choi, K. U. (2023) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2023.111705
Drzezga, A. E., & Giehl, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_5
Yoshida, Y., Yokoi, T., Hara, K., Watanabe, H., Yamaguchi, H., Bagarinao, E., Masuda, M., Kato, T., Ogura, A., Ohdake, R., et al. (2023) · PubMed Central · doi:10.18999/nagjms.85.4.758
Neurodegenerative und Demenzielle Erkrankungen
Teipel, S. J., Kurth, J., Prudlo, J., Mohnike, W., & Krause, B. J. (2024) · Springer eBooks · doi:10.1007/978-3-662-67192-4_29
Xu, L., Ren, C., Jing, C., Wang, G., Wei, H., Kong, M., Ba, M., & Initiative, A. D. N. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16376
Wang, W., Myers, S. J., Ollen‐Bittle, N., & Whitehead, S. N. (2024) · Research Square · doi:10.21203/rs.3.rs-5182325/v1
Demenzdiagnose mittels Biomarker – geht das?
Teipel, S. J. (2025) · neuroreha · doi:10.1055/a-2515-5986
Makovitzky, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-70714-8_8
Fluid and Imaging Markers of Amyloid Pathology
West, T., Meyer, M. R., Kirmess, K. M., Yarasheski, K. E., Braunstein, J. B., & Verghese, P. B. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_1
(2022) · Elsevier eBooks · doi:10.1016/b978-3-437-21884-2.00033-7
Evaluation of cognitive performance within the disease course of Alzheimer´s
Rettenwander, L. A. E. (2014) · Utrecht University Repository (Utrecht University)
Huszár, Z., Engh, M. A., Pavlekovics, M., Sato, T., Steenkamp, Y., Hanseeuw, B. J., Terebessy, T., Molnár, Z., Hegyi, P., & Csukly, G. (2024) · Figshare · doi:10.6084/m9.figshare.26705691
Torso, M., Ridgway, G. R., Valotti, M., Hardingham, I., & Chance, S. A. (2023) · Figshare · doi:10.6084/m9.figshare.24248059
Baek, M. S., Cho, H., Lee, H. S., Lee, J. H., Ryu, Y. H., & Lyoo, C. H. (2020) · Figshare · doi:10.6084/m9.figshare.13174043
O’Dell, R. S., Mecca, A. P., Chen, M.-K., Naganawa, M., Toyonaga, T., Lu, Y., Godek, T. A., Harris, J. E., Bartlett, H. H., Banks, E. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525170
O’Dell, R. S., Mecca, A. P., Chen, M.-K., Naganawa, M., Toyonaga, T., Lu, Y., Godek, T. A., Harris, J. E., Bartlett, H. H., Banks, E. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525173
Metadata
- Authors
- Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., Martins, R., O'Keefe, G., Mathis, C. A., Klunk, W. E., Ames, D., Masters, C. L., & Rowe, C. C.
- Affiliations
- Mental Health Research Institute (AU)
- Austin Health (AU)
- Commonwealth Scientific and Industrial Research Organisation (AU)
- Australian e-Health Research Centre (AU)
- Edith Cowan University (AU)
- University of Pittsburgh (US)
- National Ageing Research Institute (AU)
- The University of Melbourne (AU)
- Corresponding author
- Villemagne, Victor L.
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 69
- Issue
- 1
- Pages
- 181-192
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC3045039
- OpenAlex
- W2051489981
- Cited by
- 833
- References
- 42
- Citations by year
- 2026: 28 · 2025: 32 · 2024: 26 · 2023: 51 · 2022: 42 · 2021: 44 · 2020: 57 · 2019: 60 · 2018: 57 · 2017: 57 · 2016: 60 · 2015: 61 · 2014: 68 · 2013: 86 · 2012: 71
- FWCI
- 57.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Edith Cowan University Research Online (Edith Cowan University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG025204, RF1AG025516, P50AG005133, R37AG025516)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- amyloid-beta deposition, Alzheimer's disease, mild cognitive impairment, Pittsburgh compound B PET, APOE ε4, cognitive decline, disease progression, aging
- MeSH terms
- Aged, Aging, Alzheimer Disease, Aniline Compounds, Brain, Cognition, Cognition Disorders, Female, Follow-Up Studies, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Polymorphism, Genetic, Severity of Illness Index, Thiazoles, Amyloid beta-Peptides, Disease Progression, Positron-Emission Tomography, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
